Threshold which key parameters would need to reach for each type of HIV cure strategy to be cost-effective (ICER<$100,000/QALY gained) or cost-saving.

<p><b>ICER:</b> incremental cost-effectiveness ratio; <b>QALY:</b> quality-adjusted life year; <b>QOL:</b> quality of life; <b>Dominated:</b> strategy was less effective and more expensive than current ART.</p><p>*Cost reductions led to the strategy being less effective and less expensive than current ART. One could calculate an ICER for ART compared to Chemotherapy or Stem Cell Transplant, but it is not clinically plausible that these strategies would be used if they resulted in worse outcomes than standard of care with ART, even if they saved money by avoiding the costs of lifelong ART.</p><p>Threshold which key parameters would need to reach for each type of HIV cure strategy to be cost-effective (ICER<$100,000/QALY gained) or cost-saving.